AbelZeta Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for C-CAR168 for the Treatment of Refractory SLE, Including LN PR Newswire Nawigacja wpisu Congratulations to the Baylor College of Medicine class of 2025! – Baylor College of Medicine Blog Network – AbelZeta Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for C-CAR168 for the Treatment of Refractory SLE, Including LN – Yahoo Finance
